Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing
By Peter J. Campbell, P. Stephens, E. Pleasance, Sarah O 'meara, Heng Li, T. Santarius, L. Stebbings, Catherine Leroy, S. Edkins, Claire W. Hardy and 14 more. Nature Genetics, 2008
907 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Plant Science
View Paper: https://www.semanticscholar.org/paper/5c543beb331255796f61b6b7826f8b21b2cd64fa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Gad Getz
- Peter J. Campbell
- Daniel C. Koboldt
- S. Nik-Zainal
- David C. Wedge
- Ludmil B. Alexandrov
- Michael R. Stratton
- Elaine R. Mardis
In Genetics
- Steven L. Salzberg
- Daniel C. Koboldt
- Heng Li
- Mihai Pop
- Elaine R. Mardis
- Ben Langmead
- Richard Durbin
- Evan E. Eichler
In Plant Science
- Steven L. Salzberg
- Mihai Pop
- Paul Medvedev
- Eric S. Lander
- Heng Li
- Richard Durbin
- Inanç Birol
- Evan E. Eichler
Citations in the corpus
- Frequent pathway mutations of splicing machinery in myelodysplasia (2011, neutral): “240 aa Zn S34F(20) S34Y(5) Q157R(7) Q157P(4)”
- Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives (2013, methodology): “Earlier methods such as mrCaNaVar and CNV-seq are implemented in a model-free style [31,35,36].”
- High-resolution mapping of copy-number alterations with massively parallel sequencing (2008, background): “Recently, a new generation of DNA sequencers has enabled massively parallel sequencing of millions of short sequence reads at dramatically lower cost”
- Mechanisms and insights into drug resistance in cancer (2013, background): “The second mechanism involves the acquisition of stochastic alterations within the cancer cells which provide a survival advantage (Campbell et al., 2008; Stratton et al., 2009; Negrini et al., 2010; The International Cancer Genome Consortium, 2010; Shen, 2011).”
- cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate (2012, background): “:3) ik and new i to zero according to Equation (6) and Equation (7).”
- Genome structural variation discovery and genotyping (2011, methodology): “Read-depth approaches using NGS data were first applied to define rearrangements in cance”
- Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. (2012, background): “The read depth of exome sequencing for an exon target is a function of a number of biochemical properties of the genome, in addition to experimental and bioinformatic steps including genomic fragmentation, array hybridization (‘‘capture’’), PCR,(23) sequencing,(24) and in silico alignment to the ref”
- DELLY: structural variant discovery by integrated paired-end and split-read analysis (2012, background): “DELLY, thus, enables to ascertain the full spectrum of genomic rearrangements, including complex events.”
- CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. (2011, methodology): “Previous approaches using RD were limited to only unique regions of the genome (Bentley et al. 2008; Campbell et al. 2008; Chiang et al. 2009), discovered only large CNVs with poor breakpoint resolution (Bentley et al. 2008; Campbell et al. 2008; Alkan et al. 2009; Chiang et al. 2009), or could not…”
- COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer (2009, neutral): “More recently, CGP data includes low coverage whole genome resequencing screens (2), utilizing nextgeneration sequencing technologies which can precisely identify genome-level rearrangements previously invisible in both karyotypic and candidate gene screen procedures.”
- A census of amplified and overexpressed human cancer genes (2010, background): “This distinction is important because activation of cancer genes by mutation or translocation can also be associated with their amplificatio”
- Mutational Processes Molding the Genomes of 21 Breast Cancers (2012, methodology): “Structural variants were called from the short insert data by using MAQ alignments as previously described (Campbell et al., 2008; Stephens et al., 2009).”